Hydrogen Water for Weight Loss: What Studies Show

Anyone searching online for the link between hydrogen water and weight loss will quickly come across big promises, but the actual state of the research is much more restrained. So far, no independent human study has shown that hydrogen water leads to independent, confirmed weight loss as its primary outcome. What we have is an animal study in mice and four human studies of varying quality: Some show improvements in individual metabolic markers or an effect in small subgroups, but none provides clear, repeated evidence for body weight itself. This article assesses the five available studies by sample size, study design and actual endpoint, so you can judge for yourself how much weight to give the individual findings.

• A mouse study suggests a possible mechanism, but it is not evidence in humans.
• The first pilot study in humans, which had no placebo group, showed improved metabolic markers but no change in body weight.
• The only study with a clear BMI result was partly industry-funded and does not provide isolated comparisons between groups for this measure.
• The two most recent and largest placebo-controlled studies found an effect only in small subgroups, not in the primary outcome.

What a mouse study suggests about hydrogen water and fat metabolism

The biological starting point for weight-loss marketing comes not from a human study, but from an animal model. In 2011, Kamimura and colleagues had diabetic (db/db) mice drink hydrogen-rich water and observed lower body and fat weight, as well as improved glucose and insulin regulation, mediated by an increase in the liver hormone FGF21 (source: Kamimura et al., 2011). This is a plausible mechanism worth following up, but it describes genetically obese mice under controlled laboratory conditions, not an outcome in humans. Marketing claims that cite this study as evidence of weight loss in humans confuse an animal model with a confirmed effect in people.

Most of the human studies described below selected participants with metabolic or pre-metabolic syndrome—that is, a combination of increased waist circumference, blood pressure, blood sugar or blood lipid levels that raises the risk of cardiovascular disease and type 2 diabetes. This group was presumably chosen because it might theoretically benefit most from improvements in oxidative or metabolic markers, not because an effect on weight in humans had already been demonstrated.

The first human study (2010): Metabolic markers improved, but weight did not

In 2010, Nakao and colleagues published the first human study: an open-label, eight-week pilot study with 20 participants suspected of having metabolic syndrome. There was neither a placebo group nor blinding, so expectation effects cannot be ruled out. The results were mixed: Oxidative stress markers in urine fell significantly, and the ratio of total cholesterol to HDL improved by around 13 percent, while fasting blood sugar did not change significantly (source: Nakao et al., 2010). Body weight, BMI and blood pressure remained unchanged in this study. If you want to know how such oxidation markers are measured and assessed, you can find out in the article about oxidative stress markers. For the question of weight loss, this first result mainly means that even the earliest study often cited as evidence found no effect on weight itself.

A 24-week placebo-controlled study found a lower BMI—with limitations

The randomized, double-blind, placebo-controlled study by LeBaron and colleagues from 2020 offers considerably stronger evidence by design. It followed 60 adults with metabolic syndrome for 24 weeks. The authors report a significant reduction in body weight, BMI and waist-to-hip ratio in the hydrogen water group (p<0.05), in addition to changes in blood lipid levels (source: LeBaron et al., 2020). This is the strongest single result in favor of an effect on weight to date, but it deserves a close reading: The published report does not provide isolated between-group comparisons for BMI and waist-to-hip ratio, the study was partly funded by a hydrogen water company, and the first author disclosed receiving fees related to molecular hydrogen. This does not automatically make the result wrong, but it explains why an independent replication of the study would be needed before treating it as established.

Two more recent studies (2024–2025): The effect appears only in subgroups

The two largest and methodologically most rigorous studies to date were published in the last two years, and both further qualify the picture. In 2024, Moribe and colleagues studied 181 people with metabolic or pre-metabolic syndrome in a randomized, double-blind, placebo-controlled trial over three months. In the primary comparison, waist circumference did not differ significantly between the groups (p=0.65); a difference of about 2.8 cm in favor of the hydrogen water group appeared only in the subgroup with high physical activity (p=0.01). The study was funded by the manufacturer of the ionization device used, and one co-author is employed by that company (source: Moribe et al., 2024).

The 2025 HYDRAPPET study by Todorovic and colleagues shows a similar pattern: 35 adults with obesity took part in an eight-week, double-blind, placebo-controlled study, and body weight and body composition did not change significantly in the group as a whole. A trend toward lower weight appeared only in a small male subgroup, and even there it was only borderline significant (p=0.05). Here too, one author is employed by the company that supplied the product being tested (source: Todorovic et al., 2025). Taken together, the two most recent, largest and most rigorously controlled studies found no effect on the primary outcome, and an effect only in small subgroups that were not predefined as primary targets.

How to assess a dietary supplement study like this

The five studies in this article can be assessed using the same three questions that apply to any study of a dietary supplement. Knowing these questions can also help you assess future headlines about hydrogen water more realistically. For a more detailed general guide, see the guide to reading a hydrogen water study.

Sample size and blinding

Twenty participants with no placebo group, as in the first pilot study, provide little basis for drawing conclusions about a larger population. Only randomization, a placebo group, and blinding of participants and assessors prevent expectations or assessment bias from distorting the results. Only the last three of the five studies fully meet these criteria, which makes their results fundamentally more credible than those of the first pilot study.

Primary outcome versus subgroup finding

A result that appears in the predefined primary comparison of the entire study group is different from one that becomes visible only after the group is divided into subgroups. The more subgroups are tested, the more likely it is that a significant difference will show up somewhere purely by chance. Both in Moribe 2024 and in the HYDRAPPET study, the positive finding appeared only in a subgroup, while the primary comparison showed no notable effect, making these results considerably weaker than an improvement in the actual primary endpoint.

Funding and disclosed conflicts of interest

Funding from a manufacturer or fees paid to an author do not automatically invalidate a result, but they do mean that an independent replication is needed before it can be treated as established. Three of the four human studies in this article were funded wholly or partly by a company that makes or sells hydrogen water devices, and in each case at least one author was employed by that company or disclosed receiving related fees. The article about funding and the economics of research on hydrogen water studies explains in more detail why studies on hydrogen water are so often small and independent funding is rare. This does not mean that industry-connected research is inherently worthless: Many active ingredients are first researched by their manufacturers, simply because they have the greatest interest in the question. It only means that a result should be considered established once it has also been confirmed by research teams with no financial ties to the product.

What this means if you still want to try hydrogen water

Taken together, the five studies do not support a reliable, independent weight-loss effect from hydrogen water at any point. Instead, what individual studies suggest are modest shifts in metabolic and oxidation markers, such as the cholesterol-to-HDL ratio or urinary oxidation products, and even these findings come mostly from small or industry-connected studies that have not yet received independent confirmation. The subgroup findings in physically active people and in men in the two most recent studies are best read as a starting point for future studies specifically designed to investigate them, not as an effect already proven for these groups. If you want to understand the broader question of whether hydrogen water works beyond the topic of weight, you can find a wider assessment in the article Does hydrogen water really work? An honest, evidence-based look.

If you still want to try hydrogen water, do so for other, more realistic reasons: out of curiosity, as part of a daily routine, or because of the modest changes in markers shown in individual studies, rather than as a weight-loss promise. A model like the Hydrion Core bottle, which prepares hydrogen water for everyday use, is a simple way to get started, independent of any promise of weight loss.